| Year | Title | Author(s) |
| 2025 |
BASTA, a simple whole-blood assay for measuring β cell antigen-specific CD4+ T cell responses in type 1 diabetes
Science Translational Medicine |
Lacorcia, M Bhattacharjee, P Foster, A Hardy, MY Tye-Din, JA Karas, JA Wentworth, JM Cameron, FJ Mannering, SI |
| 2025 |
Islet Autoantibody Screening Throughout Australia Using In-Home Blood Spot Sampling: 2-Year Outcomes of Type1Screen
Diabetes Care |
Wentworth, JM Sing, ABE Naselli, G Huang, DX Azidis-Yates, E Mandlebe, B Brown, JD Mcgorm, K Hall, C Redl, L Kludas, R Haldar, A Healy, F Gilbert, A Watson, K Chiang, C Couper, JJ Huynh, T Davis, EA Craig, ME Cameron, FJ Kay, TW Harrison, LC Colman, PG |
| 2024 |
A minority of proliferating human CD4+ T cells in antigen-driven proliferation assays are antigen specific
Frontiers In Immunology |
Bhattacharjee, P Pakusch, M Lacorcia, M Chiu, CY Liu, X Tresoldi, E Foster, A King, L Cameron, FJ Mannering, SI |
| 2024 |
Proinsulin C-peptide is a major source of HLA-DQ8 restricted hybrid insulin peptides recognized by human islet-infiltrating CD4+ T cells
Pnas Nexus |
Bhattacharjee, P Pakusch, M Lacorcia, M Tresoldi, E Rubin, AF Foster, A King, L Chiu, CY Kay, TWH Karas, JA Cameron, FJ Mannering, S |
| 2023 |
Glutamine deamidation does not increase the immunogenicity of C-peptide in people with type 1 diabetes
Journal Of Translational Autoimmunity |
Foster, A Bhattacharjee, P Tresoldi, E Pakusch, M Cameron, FJ Mannering, SI |
| 2022 |
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial
Trials |
Waibel, M Thomas, HE Wentworth, JM Couper, JJ MacIsaac, RJ Cameron, FJ So, M Krishnamurthy, B Doyle, MC Kay, TW |
| 2021 |
T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8
Nature Communications |
Tran, MT Faridi, P Lim, JJ Ting, YT Onwukwe, G Bhattacharjee, P Jones, CM Tresoldi, E Cameron, FJ La Gruta, NL Purcell, AW Mannering, SI Rossjohn, J Reid, HH |
| 2018 |
Proinsulin C-peptide is an autoantigen in people with type 1 diabetes
Proc. Natl. Acad. Sci. U. S. A. |
So, M Elso, CM Tresoldi, E Pakusch, M Pathiraja, V Wentworth, JM Harrison, LC Krishnamurthy, B Thomas, HE Rodda, C Cameron, FJ McMahon, J Kay, TWH Mannering, SI |